JESSICA F JOHN

Allopathic & Osteopathic Physicians|Family Medicine HOUSTON, TX NPI 1992292387

General Payments — all program years on this page

$870.01

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $243.12 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $243.1214

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
DEXCOM, INC. $51.162
Acerta Pharma LLC $48.543
Amgen Inc. $46.823
Novo Nordisk AS $35.792
Lilly USA, LLC $33.082
ABBVIE INC. $14.611
GlaxoSmithKline, LLC. $13.121

By program year

Program yearAmountRecords
2021 $26.841
2022 $324.1316
2023 $275.9215
2024 $243.1214

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097722131 Novo Nordisk Inc $18.17 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097819121 Novo Nordisk Inc $17.62 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103999293 ABBVIE INC. $14.61 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104675289 AstraZeneca Pharmaceuticals LP $18.39 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105345457 AstraZeneca Pharmaceuticals LP $13.67 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105366804 AstraZeneca Pharmaceuticals LP $16.48 08/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111610141 Amgen Inc. $15.60 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116382794 GlaxoSmithKline, LLC. $13.12 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288123 Amgen Inc. $13.35 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288125 Amgen Inc. $17.87 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135048516 Lilly USA, LLC $15.97 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135062953 Lilly USA, LLC $17.11 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153308523 Dexcom, Inc. $23.97 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153308525 Dexcom, Inc. $27.19 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.